Paradigm Medical Industries, Inc.
PDMI · OTC
3/31/2009 | 12/31/2008 | 9/30/2008 | 6/30/2008 | |
|---|---|---|---|---|
| Revenue | $153 | $353 | $463 | $213 |
| % Growth | -56.7% | -23.8% | 117.4% | – |
| Cost of Goods Sold | $71 | $192 | $248 | $122 |
| Gross Profit | $82 | $161 | $215 | $91 |
| % Margin | 53.6% | 45.6% | 46.4% | 42.7% |
| R&D Expenses | $64 | $83 | $20 | $62 |
| G&A Expenses | $128 | $0 | $0 | $0 |
| SG&A Expenses | $174 | $339 | $289 | $388 |
| Sales & Mktg Exp. | $46 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $238 | $422 | $309 | $450 |
| Operating Income | $156 | $261 | $94 | $359 |
| % Margin | 102% | 73.9% | 20.3% | 168.5% |
| Other Income/Exp. Net | -$126 | -$110 | -$171 | -$189 |
| Pre-Tax Income | -$282 | -$371 | -$265 | -$548 |
| Tax Expense | $134 | $110 | $171 | $189 |
| Net Income | -$282 | -$371 | -$265 | -$548 |
| % Margin | -184.3% | -105.1% | -57.2% | -257.3% |
| EPS | -0.18 | -2.5 | -1.91 | -7.53 |
| % Growth | 92.8% | -30.9% | 74.6% | – |
| EPS Diluted | -0.18 | -2.5 | -1.91 | -7.53 |
| Weighted Avg Shares Out | 1,559 | 149 | 139 | 73 |
| Weighted Avg Shares Out Dil | 1,559 | 149 | 139 | 73 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $134 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$147 | -$260 | -$93 | -$358 |
| % Margin | -96.1% | -73.7% | -20.1% | -168.1% |